Stock Code: 000553 (200553) Stock Abbreviation: ADAMA A(B) Announcement No. 2021-48




                                        ADAMA Ltd.

       Announcement on Trial Production of Acephate/DMPAT Project

                                      At Jingzhou Site


     The Company and all members of the Company’s Board of Directors confirm that all
     information disclosed herein is true, accurate and complete, with no false or
     misleading statement or material omission.



          ADAMA Ltd. (hereinafter referred to as “the Company”) has completed
     construction, equipment installation and commissioning of the 30,000 t/a Acephate
     Project at the Company's new manufacturing site in Jingzhou, Hubei Province. With
     the trial production plan having passed expert review, the project has entered trial
     production stage, signifying the formal commencement of operations at the new
     manufacturing site.

          I. General Information

          The Company initiated the relocation and upgrade program of the old Jingzhou
     site three years ago, aiming to bring the site to global best-in-class production, safety
     and environmental standards to support the Company's global business growth. The
     advanced facility that has now begun trial production produces Acephate and its
     intermediate DMPAT, securing the Company’s leading global position in this
     backward-integrated key molecule. Acephate is a wide-spectrum low-toxicity
     insecticide used across the world in multiple crops such as rice, wheat and cotton.

          As part of the relocation, the Company utilized the opportunity to expand the
     production capacity of this key molecule and further improve its processes and
     efficiency. In addition, the new, advanced site includes a state-of-the-art wastewater
     facility, a thermal oxidation system for the elimination of emissions and odors, and is
     designed to meet the highest international HSE standards.


                                                1
     II. Impact on the Company

     The new, purpose-built site, in an approved industrial zone, is a key component
in ADAMA’s global manufacturing layout and is expected to deliver significant
operational efficiencies and cost reductions. The transformed new site is also designed
to accommodate additional new molecules emerging from the Company’s strong
development pipeline.

     While the new site has recently resumed production and output is initially
starting at relatively low levels, the Company expects output levels to gradually ramp
up over the coming months. This return to production at the new Jingzhou site will
progressively reduce the need for incurring additional procurement costs which the
Company has endured while the plant has been suspended, and is expected to reduce
idleness charges as production and utilization levels rise over the coming months.

     III. Reminder of Risks

     It will take time for the Acephate Project to progress from the trial production
stage to reach full production and generate the envisaged economic benefits. At the
same time, during the early production stage, equipment stability as well as product
output and quality remains to be reviewed and improved. The Company may also face
the impact of changes in market environment, increased competition and other factors.
Investors are reminded to pay attention to investment risks.



     It is hereby announced.



                                                  Board of Directors of ADAMA Ltd.

                                                                  November 20, 2021




                                           2